Medication info
Stolaf Tablets 10mg (Lafutidine)

Stolaf Tablets 10mg (Lafutidine)

Prescription medicationTabletOral
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Celltrion Pharmaceutical
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601643 · Approved 2016.03.28 · Insurance code 693902130

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), pre-anesthetic medication, and use in combination for eradication therapy
Who takes it
Adults
Adult dose
Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks, although the time to healing may vary among patients. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks, although the time to healing may vary among patients. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks, although the time to healing may vary among patients. Combination antibiotic therapy for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. Preanesthetic medication: The usual dose of lafutidine is 10mg orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). Treatment of reflux esophagitis: Administer lafutidine 10mg orally twice daily.

Ingredients

Manufacturer
(Co., Ltd.) Celltrion Pharmaceutical

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), pre-anesthetic medication, and use in combination for eradication therapy

  • Gastric ulcers
  • duodenal ulcers
  • acute gastritis
  • chronic gastritis
  • mucosal lesions
  • peptic ulcers
  • gastroesophageal reflux disease
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers, and improves mucosal damage caused by acute and chronic gastritis. It is also used as part of a combination therapy with antibiotics for patients with peptic ulcers due to Helicobacter pylori infection. It is utilized prior to anesthesia and helps in the treatment of gastroesophageal reflux disease. This drug is used for the treatment of various gastrointestinal diseases and the improvement of their symptoms.

How to take

Adult dose

Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks, although the time to healing may vary among patients. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks, although the time to healing may vary among patients. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks, although the time to healing may vary among patients. Combination antibiotic therapy for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. Preanesthetic medication: The usual dose of lafutidine is 10mg orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). Treatment of reflux esophagitis: Administer lafutidine 10mg orally twice daily.

Precautions

This medication should not be used in patients who are allergic to its components. It contains lactose, so patients with genetic conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should avoid taking it. Patients with a history of hypersensitivity to the drug, those with liver or kidney function impairment, patients undergoing dialysis, and the elderly should take this medication with caution. This drug can cause severe allergic reactions such as anaphylaxis; if symptoms such as facial pallor, drop in blood pressure, generalized rash, or difficulty breathing occur, stop taking it immediately and consult a healthcare professional. Liver function may be affected, so if there are elevated liver enzymes or symptoms of jaundice, discontinue use and seek medical attention. Serious side effects such as agranulocytosis or thrombocytopenia may occur, so if symptoms such as sore throat, generalized malaise, or fever appear, consult a doctor immediately. Other rare side effects reported include skin rashes, seizures, interstitial nephritis, and rarely cardiac-related symptoms, so caution is advised. Gastrointestinal symptoms may include constipation, diarrhea, nausea, vomiting, abdominal bloating, and loss of appetite, and neurological symptoms such as headache, insomnia, and drowsiness have also been reported. The elderly, having reduced physical function, should be cautious of dosage and intervals, and their condition should be closely monitored. Dialysis patients may experience increased drug concentrations, so they should start with a low dose cautiously. Pregnant women should only take this drug if the benefits outweigh the risks as judged by a doctor, and lactating women are advised not to take it as it may be excreted in breast milk. Safety in children has not been established, so caution is necessary. This drug should be kept out of reach of children and stored in its original container to prevent misuse or deterioration of quality. If a malignant tumor is suspected, testing must be done before taking this medication, and if diagnosed with malignant gastric cancer, use should be discontinued immediately. During treatment, the course of the disease should be monitored carefully, and if ineffective, alternative treatments should be considered. No carcinogenic effects were observed in animal studies; however, hyperplasia of endocrine neurons has been reported at high doses, so recommended dosages should be adhered to.

Side effects

  • Shock
  • anaphylaxis symptoms
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • hepatic dysfunction
  • jaundice
  • agranulocytosis
  • pharyngodynia
Show 81 more
  • malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Lyell syndrome
  • rhabdomyolysis
  • heart block
  • decreased contractility
  • constipation
  • diarrhea
  • hard stools
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • consciousness disturbances
  • dizziness
  • chills
  • feeling of heat
  • facial redness
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decreased hematocrit
  • elevated ALT
  • elevated AST
  • elevated Al-P
  • elevated γ-GTP
  • elevated T-Bil
  • elevated LDH
  • elevated TTT
  • abnormal urinary protein
  • elevated BUN
  • increased serum uric acid
  • elevated Cl
  • delayed growth
  • elevated Na
  • decreased K
  • gynecomastia
  • edema
  • malaise
  • glossitis
  • headache
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • nasopharyngitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • carotid artery stenosis
  • cough
  • oropharyngeal pain
  • oral pharyngeal discomfort
  • wet cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • nonalcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius in a cool, dry place.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.